Streetbeat News

Analyst Ratings

AAPL

GOOGL

META

MSFT

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo discusses trade strategies for SPY, QQQ, AAPL, MSFT, TSLA, META, and GOOGL. The memo provides price levels for these assets based on a proprietary formula that considers price, volume, and options flow. The memo suggests traders to monitor these stocks closely and be prepared to leverage potential breakouts or reversals.

Portfolio Pulse from RIPS

September 25, 2023 | 2:29 pm

CRC

Mizuho analyst Nitin Kumar has reiterated a 'Buy' rating on California Resources (NYSE:CRC) and maintained a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:27 pm

IREN

Cantor Fitzgerald analyst Josh Siegler has reiterated his Overweight rating on Iris Energy (NASDAQ:IREN) and maintained a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:13 pm

RARE

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) and maintained a price target of $114.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:11 pm

RPTX

Stifel analyst Benjamin Burnett maintains a 'Buy' rating on Repare Therapeutics (NASDAQ:RPTX) and raises the price target from $16 to $17.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:11 pm

AFMD

Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on Affimed (NASDAQ:AFMD) and maintained a $7 price target.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:09 pm

DRI

RBC Capital analyst Christopher Carril maintains an Outperform rating on Darden Restaurants (NYSE:DRI) but lowers the price target from $183 to $180.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:08 pm

ARMK

RBC Capital analyst Ashish Sabadra has maintained a 'Sector Perform' rating on Aramark (NYSE:ARMK), but lowered the price target from $48 to $43.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:05 pm

HRMY

Goldman Sachs has downgraded Harmony Biosciences from Neutral to Sell and reduced its price target from $40 to $31. This has resulted in a decrease in the trading price of Harmony Biosciences shares.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:04 pm

KMX

Evercore ISI Group analyst Michael Montani has maintained an 'In-Line' rating on CarMax (NYSE:KMX), but lowered the price target from $80 to $79.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2023 | 2:03 pm